CABALETTA BIO, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
CABALETTA BIO, INC. (CABA) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$4.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-13
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $2.60M, a 53.67% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$7.28M.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $3.05M.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $2.31M, a 64.13% decline year-over-year.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $7.43M, a 88.29% increase from fiscal 2024.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $3.95M, a 32.45% increase from fiscal 2023.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $2.98M.
- CABALETTA BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was -$1.19M, a 156.16% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$4.68M 10-Q · filed 2026-08-13 | -$1.63M derived: sum of 3 quarters · filed 2026-08-13 | $681.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | -$7.28M 10-Q · filed 2026-05-14 | -$4.23M derived: sum of 2 quarters · filed 2026-05-14 | -$1.92M derived: sum of 3 quarters · filed 2026-05-14 | $3.69M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $5.37M derived: sum of 2 quarters · filed 2026-03-23 | $10.97M derived: sum of 3 quarters · filed 2026-08-13 | $7.43M 10-K · filed 2026-03-23 |
| 2025-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $7.92M derived: sum of 2 quarters · filed 2026-08-13 | $4.38M 10-Q · filed 2025-11-10 | $3.81M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $2.07M 10-Q · filed 2026-08-13 | $1.49M derived: sum of 3 quarters · filed 2026-08-13 | $7.94M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$3.54M 10-Q · filed 2026-05-14 | -$4.11M derived: sum of 2 quarters · filed 2026-05-14 | $2.33M derived: sum of 3 quarters · filed 2026-05-14 | $3.89M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | -$574.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $5.87M derived: sum of 2 quarters · filed 2026-03-23 | $7.43M derived: sum of 3 quarters · filed 2026-03-23 | $3.95M 10-K · filed 2026-03-23 |
| 2024-09-30 | $6.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $8.00M derived: sum of 2 quarters · filed 2025-11-10 | $4.52M 10-Q · filed 2025-11-10 | $7.58M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.93M 10-Q · filed 2025-08-07 | $1.14M derived: sum of 3 quarters · filed 2025-08-07 | $1.79M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$3.48M 10-Q · filed 2025-05-15 | -$419.00K derived: sum of 2 quarters · filed 2025-05-15 | $240.00K derived: sum of 3 quarters · filed 2025-05-15 | $1.18M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $3.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $3.72M derived: sum of 2 quarters · filed 2025-03-31 | $4.66M derived: sum of 3 quarters · filed 2025-03-31 | $2.98M 10-K · filed 2025-03-31 |
| 2023-09-30 | $659.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.60M derived: sum of 2 quarters · filed 2024-11-14 | -$81.00K 10-Q · filed 2024-11-14 | $314.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $938.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$740.00K 10-Q · filed 2024-08-08 | -$345.00K derived: sum of 3 quarters · filed 2024-08-08 | $87.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$1.68M 10-Q · filed 2024-05-15 | -$1.28M derived: sum of 2 quarters · filed 2024-05-15 | -$851.00K derived: sum of 3 quarters · filed 2024-05-15 | $159.00K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $395.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $827.00K derived: sum of 2 quarters · filed 2024-03-21 | $1.84M derived: sum of 3 quarters · filed 2024-03-21 | -$1.19M 10-K · filed 2024-03-21 |
| 2022-09-30 | $432.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.44M derived: sum of 2 quarters · filed 2023-11-09 | -$1.58M 10-Q · filed 2023-11-09 | $151.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.01M 10-Q · filed 2023-08-10 | -$281.00K derived: sum of 3 quarters · filed 2023-08-10 | $806.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$3.02M 10-Q · filed 2023-05-11 | -$1.29M derived: sum of 2 quarters · filed 2023-05-11 | -$204.00K derived: sum of 3 quarters · filed 2023-05-11 | $326.00K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $1.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $2.82M derived: sum of 2 quarters · filed 2023-03-16 | $3.35M derived: sum of 3 quarters · filed 2023-03-16 | $2.11M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.62M derived: sum of 2 quarters · filed 2022-11-10 | $379.00K 10-Q · filed 2022-11-10 | $1.00M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $530.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$708.00K 10-Q · filed 2022-08-11 | -$82.00K derived: sum of 3 quarters · filed 2022-08-11 | $958.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$1.24M 10-Q · filed 2022-05-12 | -$612.00K derived: sum of 2 quarters · filed 2022-05-12 | $428.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.43M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $626.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.67M derived: sum of 2 quarters · filed 2022-03-17 | $2.67M derived: sum of 3 quarters · filed 2022-03-17 | $1.88M 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | $2.05M derived: sum of 2 quarters · filed 2021-11-01 | $1.25M 10-Q · filed 2021-11-01 | $2.04M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $1.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $209.00K 10-Q · filed 2021-08-05 | $996.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.13M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$797.00K 10-Q · filed 2021-05-03 | -$10.00K derived: sum of 2 quarters · filed 2021-05-03 | $120.00K derived: sum of 3 quarters · filed 2021-05-03 | $572.00K derived: sum of 4 quarters · filed 2021-05-03 |
| 2019-12-31 | $787.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $917.00K derived: sum of 2 quarters · filed 2021-03-16 | $1.37M derived: sum of 3 quarters · filed 2021-03-16 | $1.72M 10-K · filed 2021-03-16 |
| 2019-09-30 | $130.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $582.00K derived: sum of 2 quarters · filed 2020-11-10 | $934.00K 10-Q · filed 2020-11-10 | $1.03M derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $452.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $804.00K 10-Q · filed 2020-08-06 | $904.00K derived: sum of 3 quarters · filed 2020-08-06 | |
| 2019-03-31 | $352.00K 10-Q · filed 2020-05-12 | $452.00K derived: sum of 2 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $279.00K 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $179.00K 10-Q · filed 2019-12-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |